CRISPR-Cas9 을 활용한 A53T-SNCA 과발현 파킨슨모델 치료CRISPR-Cas9 gene-editing protects from the A53T-SNCA overexpression-induced pathology of Parkinson’s disease in vivo
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.